Proactive process evaluation of precision medicine platforms: a roadmap

TL;DR

This paper outlines a framework to evaluate precision medicine platforms, focusing on how they integrate with healthcare systems and manage risks.

Contribution

The novelty lies in proposing a theory-informed proactive evaluation framework for precision medicine platforms.

Findings

Current precision medicine platforms lack evaluation of unintended consequences.

A proactive framework is needed to address infrastructural and socio-organisational challenges.

Agile evaluation approaches are essential for sustainable innovation in precision medicine.

Abstract

Precision and genomic medicine have significant potential to improve population health. However, despite rapid technological development and increasing data complexity, practical applications of precision medicine remain limited. There is also a lack of evaluation of unintended consequences and a failure to use theory-based implementation frameworks to manage risks and ensure sustainability.

This work provides a conceptual overview of evaluation challenges related to precision medicine platforms, based on existing literature. It proposes a theory-informed proactive process evaluation framework to guide the development and assessment of these platforms.

The proposed framework considers infrastructural, socio-organisational and system-level factors. It raises key questions, such as: How will platforms integrate with existing infrastructures? How will they transform care pathways and the delivery of care across settings?

Rapid technological advances challenge markets and regulatory environments. Agile evaluation approaches are crucial for building a sustainable innovation ecosystem for precision medicine platforms.

Figures